Bio Green Med Solution, Inc. (BGMSP) Net Equity Issued and Repurchased (2010 - 2026)

Bio Green Med Solution (BGMSP) has reported Net Equity Issued and Repurchased for 15 consecutive years, with $125000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Net Equity Issued and Repurchased fell 96.79% year-over-year to $125000.0; the TTM figure through Mar 2026 stood at $2.7 million (down 45.72% YoY), while the FY2025 annual figure was $6.4 million, up 3.48% from the prior year.
• Net Equity Issued and Repurchased declined to $125000.0 in Q1 2026 per BGMSP's latest filing, from $861000.0 in the prior quarter.
• Across five years, Net Equity Issued and Repurchased topped out at $3.9 million in Q1 2025 and bottomed at -$3000.0 in Q3 2025.
• Historically, Net Equity Issued and Repurchased has averaged $1.1 million across 3 years, with a median of $493000.0 in 2025.
• Annual changes were most pronounced in 2025 — Net Equity Issued and Repurchased plunged 200.0% — and 2026, when it sank 96.79%.
• Bio Green Med Solution's Net Equity Issued and Repurchased stood at -$1000.0 in 2024, then jumped by 86200.0% to $861000.0 in 2025, then plunged by 85.48% to $125000.0 in 2026.
• Business Quant data shows BGMSP's Net Equity Issued and Repurchased at $125000.0 in Q1 2026, $861000.0 in Q4 2025, and -$3000.0 in Q3 2025.